There may be several reasons why the effects of IGF-1 on cell proliferation in the OFs of patients with TAO differ from those in control subjects, but we thought that the difference in the expression levels of IGF-1R between the OFs of patients with TAO and control subjects might be involved. The gene discussed is IGF1R; the disease is thromboangiitis obliterans.